Bereits seit vielen Jahren stellen sich die Mitglieder des Evin Hub gemeinsam komplexen Forschungsfragen. Im Bereich Real-World Evidence können wir einen fundierten wissenschaftlichen Track Record zu verschiedenen Indikationen und Therapiefeldern vorweisen. Dieser belegt, dass wir nicht nur erfolgreich Forschung betreiben, sondern auch ein vertrauensvoller Ansprechpartner für viele namhafte Auftraggeber sind.
Versorgungsrealität stationär behandelter Patienten mit proximaler Humerusfraktur – Eine Analyse auf Basis von GKV-Daten. Zeitschrift fur Orthopadie und Unfallchirurgie, 161(4), S. 439–446. (Originaltitel „Health Care for Inpatients with a Proximal Humeral Fracture - an Analysis of Health Insurance Data“). DOI: https://doi.org/10.1055/a-1716-2218.
Therapy areas: Bone
Indications: Osteoporosis
Versorgung geriatrischer Krankheitsbilder unter ausgewählten ambulanten Facharztgruppen: Kombination von Befragungs- und GKV-Routinedaten zur Abbildung des Leistungsgeschehens. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 178, S. 37–46. DOI:https://doi.org/10.1016/j.zefq.2023.02.006 (abgerufen am 15.11.2023).
Therapy areas: Geriatrics
Indications: Geriatric diseases
Treatment sequences and time on specific treatments in patients with inflammatory bowel disease under advanced treatment – a German claims data analysis Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1870–i1872 https://doi.org/10.1093/ecco-jcc/jjad212.1167
Therapy areas: Gastroenterology
Indications: Inflammatory bowel disease
Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany. Urol Int. 2020;104(11-12):982-993. doi: 10.1159/000509973.
Therapy areas: Oncology/Hematology
Indications: Metastatic Renal Cell Carcinoma
Unveiling the untreated: development of a database algorithm to identify potential Fabry disease patients in Germany. Orphanet J Rare Dis (2024). https://doi: 10.1186/s13023-024-03258-y.
Therapy areas: Rare Disease
Indications: Rare Disease - Fabry
Treatment patterns in patients with cow’s milk protein allergy (CMPA) in a German Sickness Fund Database. EAACI-PAAM 2017 meeting, London No DOI/URL available
Therapy areas: General Health
Indications: Cow's Milk Protein Allergy
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort Study. Infectious diseases and therapy. DOI:https://doi.org/10.1007/s40121-024-00973-8.
Therapy areas: Urology
Indications: Urinary Tract Infection
Treatment escalation in polyarticular juvenile idiopathic arthritis: a population in Germany in 2014 and 2015—a retrospective observational health claims data study. Proceedings of the 29th European Paediatric Rheumatology Congress. Pediatric Rheumatology, 21(122), Artikel PT073. DOI:https://doi.org/10.1186/s12969-023-00879-8 (abgerufen am 06.11.2023).
Therapy areas: Immunology
Indications: Juvenile idiopathische arthritis
Treatment patterns in a polyarticular juvenile idiopathic arthritis population in Germany. A retrospective observational health claims data study. In: J. S. Smolen (Hrsg.). Abstracts. EULAR European Congress of Rheumatology. [Sonderheft]. EULAR 2023 31 May-3 June 2023. Annals of the Rheumatic Diseases, 82(Supplement 1), S. 1951–1952. Online: https://congress.eular.org/myUploadData/files/eular_2023_abstract_book.pdf (abgerufen am 27.10.2023).
Therapy areas: Immunology
Indications: Juvenile idiopathische arthritis
Treatment and Associated Outcomes of Type-2 Diabetes Mellitus Patients with a Cardiovascular Comorbidity and Comparison With Guideline Recommendations: A German Claims Data Analysis. Value in Health, Volume 26, Issue 11, S2 (December 2023) No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany. Rheumatol Ther 22 January 2024; https://doi.org/10.1007/s40744-023-00635-0
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
Treatment and Associated Outcomes of Type-2 Diabetes Mellitus Patients With a Cardiovascular Comorbidity and Comparison With Guideline Recommendations: A German Claims Data Analysis. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3784/133118 (abgerufen am 03.01.2024).
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther. 2021 Feb 5. DOI: 10.1007/s40744-021-00277-0.
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
Socioeconomic Burden of Obesity – Increased Rate and Duration of Sick Leave in Patients Living with Obesity: A Cross-Sectional Claims Data Analysis in Germany. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3784/129723 (abgerufen am 03.01.2024).
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Obesity
The Burden of Organ Damage Among Patients With Systemic Lupus Erythematosus in Germany. International Congress on Systemic Lupus Erythematosus (LUPUS & CORA 2021) No DOI/URL available
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
Similarities and differences between real world patient data sources: a global case study. ISPOR 22nd Annual Internationl Congress 2017, Boston No DOI/URL available
Therapy areas: General Health
Indications: General
Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx). European Respiratory Journal 2020 56: 4189. DOI: 10.1183/13993003.congress-2020.4189
Therapy areas: Respiratory
Indications: COPD
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB. World J Urol (World Journal of Urology), 39, S. 2953–2960. DOI:https://doi.org/10.1007/s00345-020-03587-0 (abgerufen am 01.11.2023).
Therapy areas: Oncology/Hematology
Indications: Bladder Carcinoma
Retrospective Analysis of Patients With Prostate Cancer Initiating GnRH Agonists/Antagonists Therapy Using a German Claims Database: Epidemiological and Patient Outcomes. Front. Oncol. (Frontiers in Oncology), 8, S. 543. DOI:https://doi.org/10.3389/fonc.2018.00543 (abgerufen am 02.11.2023).
Therapy areas: Oncology/Hematology
Indications: Prostate cancer
Retrospektive GKV-Versorgungsforschungsstudie über GnRH-Antagonisten/-Agonisten zur initialen Therapie des fortgeschrittenen Prostatakarzinoms – Verordnungsmuster und Krankenhauskosten in Deutschland. Aktuelle Urologie, 51(3), S. 275–284. (Originaltitel „Retrospective SHI (Statutory Health Insurances) real-world study on initial GnRH antagonist and agonist therapy for advanced prostate cancer: prescription patterns and hospital costs in Germany“). DOI: https://doi.org/10.1055/a-1018-1651 (abgerufen am 02.11.2023).
Therapy areas: Oncology/Hematology
Indications: Prostate cancer
Sie sehen gerade einen Platzhalterinhalt von OpenStreetMap. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Mehr InformationenSie sehen gerade einen Platzhalterinhalt von Google Maps. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Mehr Informationen